| NuVi NUTIFOOD NUTRITION FOODJOINT STOCK COMPANY 2207279 29 Jun 2022 | on 22 Jan 2025 | Dietetic foods adapted for medical use for general health and well-bei... Class 005 Class 005 Pharmaceutical Products Dietetic foods adapted for medical use for general health and well-being; nutritional supplements for general health and well-being; food for infants; medical preparations for slimming purpose; dietetic beverages for babies adapted for medical purposes; diabetic fruit juice beverages adapted for medical purposes; nutritional supplement meal replacement beverages containing vitamins and minerals; nutraceutical beverages for general health and well-being; lacteal flour for infants Class 029 Class 029 Meats and Processed Food Products Grain-based beverages used as a milk substitute; milk and milk products, excluding ice cream, ice milk and frozen yogurt; milk beverages with milk predominating; kefir; yogurt; cheese; vegetable-based snack foods; swallow's nest soup Class 030 Staple Food Products Tea-based beverages; coffee-based beverages; cocoa-based beverages; coffee; cocoa; confectionery, namely, cakes, candies, biscuits, cookies; ready-to-eat cereals; ice cream; porridge; chocolate-based beverages with milk; cereal-based snack foods
Class 032 Light Beverage Products Non-alcoholic beverages containing swallow's nests; mineral waters [beverages]; aerated waters; non-alcoholic beverages made from fruits and vegetables; non-alcoholic cider; non-alcoholic soft drinks; fruit-based beverages; protein-enriched sports beverages; grain-based beverages, other than milk substitutes; non-alcoholic, non-carbonated fruit flavoured beverages; syrups for beverages; essences for making non-alcoholic beverages; frozen fruit and vegetable mixes for making beverages; concentrates for making fruit beverages; mixes in the nature of powders used in the preparation of flavored non-alcoholic beverages; powders used in the preparation of fruit-based beverages | |
| V IVUVI ALPIN AKTIF GIYIM SANAYI VE TICARET ANONIM SIRKETI 2160978 21 May 2021 | on 27 Sept 2023 | Swaddling baby clothing; swaddling infant clothing; clothing for domes... Class 025 Class 025 Clothing Products Swaddling baby clothing; swaddling infant clothing; clothing for domestic use, namely, aprons; ladies' suits; pant suits; skirt suits; trouser suits for women; women's suits; head covers, namely, head scarves, hats; clothing, namely, bluejeans, bathing and beach clothing, namely, bathing suits, underwear, undershirts, undershorts, panties, brassieres, underskirts, camisole, flannels, namely, flannel pajamas; booties, bustier, corsets, dressing gowns, night gowns, coats, raincoats, mackintoshes, trench coats, jackets, trousers, skirts, dresses, vests, shirts, t-shirts, sweat shirts, pullovers, cardigans, sweaters, blouses, shorts, bermuda shorts, overalls, jump suits, hospitality and restaurant uniforms; military uniforms; nurses' uniforms; uniforms for employees of the food service industry; uniforms for medical personnel; waiter's uniforms; school aprons, socks; footwear, namely, shoes, boots, top boots, slippers and booties and parts thereof; sporting shoes and nails thereof, namely, cleats for attaching to shoes; parts of shoes, namely, soles, heels, side and upper parts for Japanese style sandals; headwear, namely, caps, hats, berets; undershirts for babies; nylon underpants; clothing accessories, namely, garment collar inserts, false collars, bandannas, garters, belts, neckties, bow ties, gloves, shawls, head strips, namely, sweat bands; cuffs. | |
| MINJUVI INCYTE HOLDINGS CORPORATION 2067066 19 Oct 2020 | on 21 Jun 2023 | Pharmaceuticals and pharmaceutical preparations for human for the trea... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals and pharmaceutical preparations for human for the treatment and prevention of cancer, restenosis and metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, chronic obstructive pulmonary disease, inflammatory diseases of the thyroid, pelvic inflammatory disease, arthritis, asthma; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; diagnostic preparations for medical diagnostic use; biological substances for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases of the thyroid and pelvic region, Alzheimer, sepsis, and restenosis; medical diagnostic reagents; clinical medical reagents for medical use; biological preparations for medical purposes for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis. Class 042 Class 042 Computer & Software Services & Scientific Services Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research, clinical research and medical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; providing medical and scientific research information in the field of pharmaceuticals; research and development services in the field of antibodies. | |
| MEKTRUVI ARRAY BIOPHARMA INC. 2022228 13 Apr 2020 | on 28 Dec 2022 | Pharmaceutical preparations for the treatment of cancer. Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of cancer. | |
| QULPRUVI GLAXO GROUP LIMITED 2018497 19 Feb 2020 | on 13 Jul 2022 | Pharmaceutical preparations for use as anti-infectives; pharmaceutical... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment of viral conditions namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone, androgen and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders, namely, acid reflux and gastroesophageal reflux disease; pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor and menopausal symptoms, endometriosis and uterine fibroids, Leiomyoma, endourological disorders and for the removal of renal calculi and the treatment of nephrolithiasis and urolithiasis, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely prophylactic and therapeutic vaccines for humans; pharmaceutical preparations for the treatment of neurological diseases and disorders namely Parkinsons Disease, Alzheimers Disease, Huntingtons Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; pharmaceutical preparations for the treatment of muscular dystrophy; Vaccines for human use. | |
| TRESUVI AOP ORPHAN PHARMACEUTICALS GMBH 2017135 28 Jan 2020 | on 20 Apr 2022 | Pharmaceutical preparations for the treatment of pulmonary hypertensio... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of pulmonary hypertension | |
| HOPRUVI GLAXO GROUP LIMITED 2012997 13 Jan 2020 | | Pharmaceutical and medicinal preparations and substances; vaccines. Class 005 Class 005 Pharmaceutical Products Pharmaceutical and medicinal preparations and substances; vaccines. | |
| MONJUVI INCYTE HOLDINGS CORPORATION 2008876 29 Nov 2019 | on 26 Oct 2022 | Pharmaceuticals and pharmaceutical preparations for human and veterina... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of cancer, restenosis and metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, chronic obstructive pulmonary disease, inflammatory diseases of the thyroid, pelvic inflammatory disease, arthritis, asthma; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; biological substances for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases of the thyroid and pelvic region, Alzheimer, sepsis, and restenosis; medical diagnostic reagents; clinical medical reagents for medical use; biological preparations for medical and veterinary purposes for use in the treatment of metabolic disorders, cancer, restenosis, and inflammatory diseases in the nature of rheumatoid arthritis, Crohn's disease, multiple sclerosis, inflammatory connective tissue diseases, irritable bowel disease, irritable bowel syndrome, colitis, pelvic inflammatory disease, and scleroderma. Class 042 Class 042 Computer & Software Services & Scientific Services Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research, clinical research and medical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; providing medical and scientific research information in the field of pharmaceuticals; research and development services in the field of antibodies. | |
| FIMLUVI GLAXO GROUP LIMITED 1998261 2 Oct 2019 | on 20 Jul 2022 | Pharmaceutical preparations for use as anti-infectives; pharmaceutical... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment of viral conditions namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of bloodrelated diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone, androgen and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders, namely, acid reflux and gastroesophageal reflux disease; pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor and menopausal symptoms, endometriosis and uterine fibroids, Leiomyoma, endourological disorders and for the removal of renal calculi and the treatment of nephrolithiasis and urolithiasis, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely prophylactic and therapeutic vaccines for humans; pharmaceutical preparations for the treatment of neurological diseases and disorders namely Parkinsons Disease, Alzheimers Disease, Huntingtons Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; pharmaceutical preparations for the treatment of muscular dystrophy; Vaccines for human use. | |
| RUVI CACHE FUTURES INC. 1972424 24 Jun 2019 | on 16 Nov 2022 | Fruit beverages; Fruit drinks; Fruit juices; Fruit-based beverages; Ve... Class 032 Class 032 Light Beverage Products Fruit beverages; Fruit drinks; Fruit juices; Fruit-based beverages; Vegetable drinks; Vegetable juices; Vegetable-fruit juices; Vegetable-based beverages | |